Showing results (471-480 of 483) with videos related to
Sort By:
Pageof 49
BMJ Open|July 7, 2016
Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural cathetersMaree Azzopardi, Rajesh Thomas, Sanjeevan Muruganandan, et al.Biotechnology and Bioengineering|September 29, 2021
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needsCarina C D Joe, Jinlin Jiang, Thomas Linke, et al.The Journal of Clinical Investigation|December 11, 2012
Vertical T cell immunodominance and epitope entropy determine HIV-1 escapeMichael K P Liu, Natalie Hawkins, Adam J Ritchie, et al.Alimentary Pharmacology & Therapeutics|August 29, 2015
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysisP De Cruz, M A Kamm, A L Hamilton, et al.Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.Molecular Psychiatry|April 13, 2016
Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated lociD J Smith, V Escott-Price, G Davies, et al.Gastroenterology|January 27, 2015
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgeryEmily K Wright, Michael A Kamm, Peter De Cruz, et al.BMC Genomics|June 29, 2017
Functional Annotation of All Salmonid Genomes (FAASG): an international initiative supporting future salmonid research, conservation and aquacultureDaniel J Macqueen, Craig R Primmer, Ross D Houston, et al.Lancet (London, England)|November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMaheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.Pageof 49